Ben Griffin
About Ben Griffin
Ben Griffin: Director of Biotechnology
Ben Griffin holds the position of Director of Biotechnology with nearly fifteen years of senior R&D leadership experience. His career spans multiple high-profile roles at leading biotechnology companies. Griffin's leadership focuses on advancing microbial and enzyme biocatalysts, demonstrating his commitment to global sustainability challenges through innovative solutions in biotechnology.
Education and Expertise of Ben Griffin
Ben Griffin earned his Bachelor of Science in Biology from the University of Puget Sound. He later obtained a PhD in Microbiology and Environmental Toxicology from Michigan State University. Griffin furthered his expertise through postdoctoral research at the University of Konstanz in Germany and the Institute for Genomic Biology at the University of Illinois Urbana-Champaign. His specialized knowledge lies in microbial physiology and genetics.
Ben Griffin's Leadership in Biotechnology Companies
Throughout his extensive career, Ben Griffin has made significant strides in biotechnology. At Genomatica, he oversaw teams of enzyme engineers, synthetic biologists, and automation engineers. His leadership at Synthetic Genomics led to technological advancements in non-photosynthetic microbial technologies. Griffin is dedicated to developing efficient and effective strain development platforms, merging advanced tech with a solid scientific foundation.
Ben Griffin's Research and Publications
Ben Griffin has several publications in Science, unveiling novel microbial physiologies. His research contributions enhance the understanding of microbial processes and their applications in biotechnology. These publications highlight Griffin's role in advancing scientific knowledge and his impact as a thought leader in the biotechnology field.
Technological Advancements Under Ben Griffin
Ben Griffin's work at Synthetic Genomics and Genomatica showcases his ability to facilitate the development of bio-based chemicals from pre-pilot to commercial scales. His leadership in developing non-photosynthetic microbial technologies and strain development platforms underscores his commitment to leveraging biotechnological advancements to address global sustainability challenges. Griffin's efforts ensure that cutting-edge technology is supported by a robust scientific and operational foundation.